{"name":"Astellas Pharma Korea, Inc.","slug":"astellas-pharma-korea-inc","ticker":"","exchange":"","domain":"astellaspharmakorea.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Corticosteroid","genericName":"Corticosteroid","slug":"corticosteroid","indication":"Other","status":"marketed"},{"name":"Advagraf","genericName":"Advagraf","slug":"advagraf","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Corticosteroid","genericName":"Corticosteroid","slug":"corticosteroid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Advagraf","genericName":"Advagraf","slug":"advagraf","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOODhpanA4RE81SVJHSVF4YXBzSmFkQl9WclF1NTJ3dWhqSjRBLVVOUTdLZkFYVWdzdXRGVWpjVzY4enVTUEU1b1gzUm5LM18tT0tNMGFhR01Fd21nN25CdjNJVjY0M1g4dkJZVk9nblRKT3ZBQUlCcGJNTEVKSHpqZ0NhbElLN3lETUVNSHBUU1ZnaWkwWWpicWhhUFZrMzJMakhNU0E5eGc?oc=5","date":"2026-03-13","type":"pipeline","source":"Fierce Pharma","summary":"Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall - Fierce Pharma","headline":"Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQb082MFprbTJ4SmVWOTFMU3RRanhUckhQU1RXZ2xDZnZRUUo4NXBrV1d1N0lwaHp2cllrMXNNcXRVY1hjMU5KRDhLb0xkVjllYVcxZFl2eFByM01jS3cxZ2lPWjVFRVYwREVIYWZLLXE5anRUaUNUV1dVTlQxZlh2WGFHYjlrWjRfZmlGV2lzajJqTjRQQjlaUy1BWmNDeWoyX0dKY0xDclB5akYxWmllVHgxblJxa0JSa2Z1RWhPWQ?oc=5","date":"2026-03-06","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC - Fierce Pharma","headline":"Fierce Pharma Asia—Kyowa ends OX40 program; Sanofi licenses first-in-class drug; BioNTech advances Duality ADC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE93ZlN1WUs1U19pVlg0ekY0Uld1NmpsLUlQa2hraGh3M01ENWE1a011ZXItbG0zMC1jYTA0aFFIVHd5TFZ6bnZDNmJPNVZrSDNILWRKS296cEN4T1dBX0hRT1lEa2QtTVlCMVFWcEtR0gFyQVVfeXFMUHFpS19oMGlIWERyQzI3ZWhQRVZHWWpCbVM1Vm9HbWR3NUtSX3RUbEJjS2pRX2FnSHJfQll3ak16NG03dE52cDhLNHpTYmUtTjVKMkZVeHFGOGxMbEVUQk1sSUpqQlZhdGxCT2c1VFhSd1FB?oc=5","date":"2025-07-21","type":"pipeline","source":"koreabiomed.com","summary":"Astellas Korea’s Lee Seon-hee appointed GM of Astellas Egypt - koreabiomed.com","headline":"Astellas Korea’s Lee Seon-hee appointed GM of Astellas Egypt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQNGlsSFNzaklKUzJlTHVHSXlRYWo0S2dRclpTRkhJMzN5Z3MwaTIzeUZ3ZHVtWlBvMHpHS2QtVnlqcmRzN1hwWmxLWXluTlJ5TXlqelJWS3hZOGZGSUpWYUQ5RHlsNlFRdTBvT09IM2k3cHUtZ1RVcFR3eVlodUFnSzZ0LXh0QmlSQ0xnVg?oc=5","date":"2025-07-18","type":"pipeline","source":"Pharmaceutical Technology","summary":"Astellas and KISED link to support Korean pharma startups - Pharmaceutical Technology","headline":"Astellas and KISED link to support Korean pharma startups","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-17","type":"deal","source":"prnewswire.com","summary":"Astellas Announces a Partnership with the \"Korea Institute of Startup and Entrepreneurship Development\", an Umbrella Organization of the \"Ministry of SMEs and Startups\", a Korean Government Agency, fo","headline":"Astellas Announces a Partnership with the \"Korea Institute of Startup and Entrepreneurship Development\", an Umbrella Org","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE41anQwdU9pSXVJYzdYLUlNSFNRYnIxZU5vQU9iNERJUXV3Vlp1YWJfQ09Kc3NqNXRobE0tMGw3OWpjUEd4ZFVYdGlWaXJacDBVUEoyZVdwTkNoMEk3azlVakd6LVBQbDA0c3dsVHRB0gFyQVVfeXFMUDRUc0tMOHgwVTBmd2ZNRmllQzluSHR2ekFoRWZhOEJBWmg2SEU5SlRYWXJyZ3ZaQ0JsVk9VV3lzRXFVaUFrNFRydlZnTXdOenp6alhVYzF2c25iMUdZWTdxVlhCS1g1NHRCLTNjMFBOTXNB?oc=5","date":"2025-07-01","type":"pipeline","source":"koreabiomed.com","summary":"Astellas Korea appoints ex-Daiichi Sankyo exec as market access head - koreabiomed.com","headline":"Astellas Korea appoints ex-Daiichi Sankyo exec as market access head","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB1bnNKTk9ISGVmT2tRUXdjV0JYZm5McU9YbEdRSUpuR3NtOGtPM05IZnNuUkllR0stR0lMR0g2MTJfaFhBTDhha3FGSWpObkprZTcyYmtpZUlydEszeXRITElqZjBqX3hFQm5kWkxR0gFyQVVfeXFMUGY5LWM3UG1pVVlualJvVDJkNnNMeC14VkZ2c2szTXhZNWwxcEVzWXNqQTZ4dzh1dllQZ3hjNWJYTWNCeGlZcWczVzdrNFVIUmgtaVBQM1pIRkkxQVFpX0M4RVY1OUgzaDFrN3VSaWYyWmx3?oc=5","date":"2025-05-07","type":"pipeline","source":"koreabiomed.com","summary":"Astellas Korea names ex-Novartis exec Kang as head of medical affairs - koreabiomed.com","headline":"Astellas Korea names ex-Novartis exec Kang as head of medical affairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPTEEzWTdwZG9TcW9oNzMzQVRveUJIUWI3UHFfQ3FBeWczbFN0eTNoLWM0Z3hTeVItWUFxN2NRNFNzaldKMmJvMXNjYUFvMld5T1hLdDNsYjVwTmVkaENIeHdXTlVfdjV5eVlkdjZqRVhxXzd6elBXaTZhTlVVR05ENGE5enRvYU5pcGFoUFZDTDlrNThyazJ2S1dmeTVuc2lvT3R4N2hjeW12WVEyaERoRTdWY0Q2Vl8tNVpoY0tUazZURnZ3akwxNA?oc=5","date":"2025-01-21","type":"pipeline","source":"Citeline News & Insights","summary":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","headline":"The World’s Top 100 Pharma Companies: 2024 Sales Rankings - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNWUQteENvX2l3YnZLZmxObzZ1dlQtWmNPYmM3TFNvOXRPMW52a3NvYnU1LXFQSGg2NEw3amlpQVo2dlJFdUtLRmxzNTdkWENWNnhjaXM5aENCMjdjbTNQVDgwRmdmbHpSXy1obHkwTmhqMXRibzBJS3dUcmJjTzJnT3RmRzdGVE1iNEV6bV94S09mNVlpMFp5ZTZIZ0d3MTA?oc=5","date":"2024-06-11","type":"pipeline","source":"BioWorld News","summary":"Abtis tapping ADC market with Claudin18.2-targeting AT-211 - BioWorld News","headline":"Abtis tapping ADC market with Claudin18.2-targeting AT-211","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5ZWFpzVUtDMEtpSUlVUEw4cFJ6enZsamdBQzZfX3AxenRFYS0yUkRZbXdQaW90TXV1WmdKZHlSUTlpNVFjelI0dlk2enQ3V1ZEbDBBbGZDT0Z4RHVYSC1kVnRCSHFKUlRC?oc=5","date":"2022-06-23","type":"pipeline","source":"Wiley Online Library","summary":"Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open - Wiley Online Library","headline":"Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNWUNtMk1QU210X1BZcE16Zmh2SWpVel9yandfVUVxbDg3ZERjTXRWdXpkT294NmlsNDhOTk9YN0hkc212WWtCZXNOMC1wRWw1amY2ODNCUmU5YUFqSUpSdk92UThaczNteGk4LXJZUDhfcXhIYURsb1VnNDlpWEw2TDJDYWFzNUxjZGRaNXBCUmF0S3NQdVlPei1uUThRTmMxeTNGRDJMb19WTkpiYXB3VWxocmFwNlNoNkE?oc=5","date":"2022-02-10","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Astellas Weighs Move into Exosomes - Genetic Engineering and Biotechnology News","headline":"Astellas Weighs Move into Exosomes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTE9aaEI5MGY4WkxFbWVzZzhHNHNseVhfZW83Q2NpSU1ES0oyeXlBLXRDb2pRaDFvZzQ2X2ZNYXhKMTd5eWpOY0E2N3hoVU0yYUE?oc=5","date":"2021-04-18","type":"deal","source":"Stock Titan","summary":"Latest ALPMY News - Astellas Announces a Partnership with the ... - Stock Titan","headline":"Latest ALPMY News - Astellas Announces a Partnership with the ...","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}